Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic Purpura

Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic Purpura

ConditionITP - Immune Thrombocytopenia

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18-75

SponsorSohag University

About this trial

this study amis to assess the incidence and severity of liver dysfunction in ITP patients receiving eltrombopag.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

Eltrombopag

Treatment groups

100 Participants

are divided into 1 treatment group